维生素B6注射液为维生素类药，主要适应症如下：1、维生素B6缺乏的预防和治疗，防治异烟肼中毒， 也可用于妊娠、放射病及抗癌药所致的呕吐、脂溢性皮炎等;2、全胃肠道外营养及因摄入不足所致营养 不良、进行性体重下降时维生素B6的补充;3、其他对维生素B6需要量增加的情况;4、新生儿遗传性维生 素B6依赖综合征。 格隆汇9月22日丨国药现代(600420.SH)公布，公司全资子公司国药集团容生制药有限公司(称国药容生) 收到国家药品监督管理局核准签发的《药品补充申请批准通知书》，批准维生素B6注射液增加规格并 通过仿制药质量和疗效一致性评价(称一致性评价)，核发药品批准文号。 ...

国药容生维生素B6注射液增加规格并通过一致性评价，将有利于该产品未来的市场拓展和销售。上述 事项对公司目前经营业绩不会产生重大影响。 智通财经APP讯，国药现代(600420.SH)发布公告，近日，公司全资子公司国药集团容生制药有限公司 (简称国药容生)收到国家药品监督管理局核准签发的《药品补充申请批准通知书》，批准维生素B6注射 液增加规格并通过仿制药质量和疗效一致性评价(以下简称一致性评价)，核发药品批准文号。 ...

维生素B6注射液为维生素类药，主要适应症如下：1、维生素B6缺乏的预防和治疗，防治异烟肼中毒， 也可用于妊娠、放射病及抗癌药所致的呕吐、脂溢性皮炎等;2、全胃肠道外营养及因摄入不足所致营养 不良、进行性体重下降时维生素B6的补充;3、其他对维生素B6需要量增加的情况;4、新生儿遗传性维生 素B6依赖综合征。 格隆汇9月22日丨国药现代(600420.SH)公布，公司全资子公司国药集团容生制药有限公司(称国药容生) 收到国家药品监督管理局核准签发的《药品补充申请批准通知书》，批准维生素B6注射液增加规格并 通过仿制药质量和疗效一致性评价(称一致性评价)，核发药品批准文号。 ...

国药容生维生素B6注射液增加规格并通过一致性评价，将有利于该产品未来的市场拓展和销售。上述 事项对公司目前经营业绩不会产生重大影响。 国药现代（600420）(600420.SH)发布公告，近日，公司全资子公司国药集团容生制药有限公司(简称国 药容生)收到国家药品监督管理局核准签发的《药品补充申请批准通知书》，批准维生素B6注射液增加 规格并通过仿制药质量和疗效一致性评价(以下简称一致性评价)，核发药品批准文号。 ...

国药现代公告，旗下全资子公司国药容生收到国家药监局核发的《药品补充申请批准通知书》，批准维 生素B6注射液增加1ml:0.1g规格并通过仿制药质量和疗效一致性评价。维生素B6注射液主要用于预防和 治疗维生素B6缺乏症及其他相关适应症。2024年该药品在全国公立医疗机构的销售额约为3.04亿元。截 至目前，国药容生在该项目的累计研发投入为408.85万元。此次批准有利于该产品的市场拓展和销售， 但对公司目前经营业绩影响不大。 ...

Core Viewpoint - Guangji Pharmaceutical announced that its subsidiary, Hubei Huisheng Pharmaceutical Co., Ltd., has received the approval from the Hubei Provincial Drug Administration for the re-registration of the chemical raw material Vitamin B6 [1] Group 1 - The approval includes a notification for the chemical raw material Vitamin B6, which is used in the production of Vitamin B6 tablets and injections [1]

Core Viewpoint - Guangji Pharmaceutical (000952) announced that its subsidiary, Hubei Huisheng Pharmaceutical Co., Ltd., has received the approval from the Hubei Provincial Drug Administration for the re-registration of the chemical raw material Vitamin B6 [1] Group 1 - The approved raw material is intended for the production of Vitamin B6 tablets and Vitamin B6 injection [1]

Group 1 - Dongli Machinery participated in the 2025 China Automobile Off-Road Rally Championship and won the T2.3 group championship as a club team [1] - The Arnoda-Black Bear Tire Chery Racing Team secured the T1.1 group championship [1] - Great Wall Haval Team, using Dongli Machinery's "Taihang Water" brand shock absorbers, won championships in the T2.1 and T2.E groups with a total of five vehicles [1] Group 2 - Guangji Pharmaceutical's subsidiary, Hubei Huisheng Pharmaceutical Co., Ltd., received approval from the Hubei Provincial Drug Administration for the re-registration of the chemical raw material drug Vitamin B6 [1] - The raw material is intended for the production of Vitamin B6 tablets and Vitamin B6 injection solutions [1]

Group 1 - The core point of the article is that Guangji Pharmaceutical's subsidiary, Hubei Huisheng Pharmaceutical Co., Ltd., has received approval for the re-registration of its chemical raw material Vitamin B6 from the Hubei Provincial Drug Administration, ensuring the stability and continuity of its production and sales qualifications [1] Group 2 - Vitamin B6 is used as a raw material for the production of Vitamin B6 tablets and injections, indicating its importance in the pharmaceutical industry [1] - The approval of the re-registration certificate is crucial for maintaining the company's operational capabilities in the Vitamin B6 market [1]

Group 1 - The core point of the article is that Guangji Pharmaceutical (000952.SZ) announced that its subsidiary, Hubei Huisheng Pharmaceutical Co., Ltd., received the approval notice for the re-registration of the chemical raw material Vitamin B6 from the Hubei Provincial Drug Administration [1] - The approval ensures the stability and continuity of the production and sales qualifications for Vitamin B6, which is used in the production of Vitamin B6 tablets and injections [1]